| Literature DB >> 27168061 |
Xue-Yang Wang1, Hai-Zhong Yu1, Lei Geng1, Jia-Ping Xu1, Dong Yu1, Shang-Zhi Zhang1, Yan Ma1, Dong-Qiong Fei1.
Abstract
Bombyx mori nucleopolyhedrovirus (BmNPV) is one of the primary pathogens causing severe economic losses in sericulture. However, the molecular mechanism of silkworm resistance to BmNPV remains largely unknown. Here, the recurrent parent P50 (susceptible strain) and the near-isogenic line BC9 (resistance strain) were used in a comparative transcriptome study examining the response to infection with BmNPV. A total of 14,300 unigenes were obtained from two different resistant strains; of these, 869 differentially expressed genes (DEGs) were identified after comparing the four transcriptomes. Many DEGs associated with protein metabolism, cytoskeleton, and apoptosis may be involved in the host response to BmNPV infection. Moreover, some immunity related genes were also altered following BmNPV infection. Specifically, after removing genetic background and individual immune stress response genes, 22 genes were found to be potentially involved in repressing BmNPV infection. These genes were related to transport, virus replication, intracellular innate immune, and apoptosis. Our study provided an overview of the molecular mechanism of silkworm resistance to BmNPV infection and laid a foundation for controlling BmNPV in the future.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27168061 PMCID: PMC4864234 DOI: 10.1371/journal.pone.0155341
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primers used in RT-qPCR for validation of DEGs.
| Gene ID | Forward Primer | Reverse primer |
|---|---|---|
| BGIBMGA004355 | 5' GAGAGTTCCCTTGTCGCTTGTG 3' | 5' CTCGCAGTTTGCTTTCGTAGTG 3' |
| BGIBMGA001480 | 5' CGAGATGGTGTGCTATGGGAAT 3' | 5' CGATTTGTCGTCGTTTCAGGA 3' |
| NewGene_4242 | 5' TGTCAGTCCCCTCGTTGCTTG 3' | 5' CGTTGTGGATTGGTCATCATTCA 3' |
| BGIBMGA013757 | 5' TAATGGGTTCCCTTGTGTAATGGT 3' | 5' TGTTAGCGAGGTAGTGCCTTTCA 3' |
| BGIBMGA010400 | 5' ACGGCTTGGGCGTTGCTATT 3' | 5' CGGTTATCTCCGCTTCTGTGCT 3' |
| BGIBMGA011531 | 5' CGCCTTCAGAAACACAAGTCGT 3' | 5' CGTATCCCATCCTGCTGGTAAC 3' |
| BGIBMGA013756 | 5' CCGTGGGTGCTCCCTATGAT 3' | 5' GCGGGGTTTGACGAAATGAA 3' |
| BGIBMGA007540 | 5' TTCCCATCGTCAAAGAACTCG 3' | 5' TTAGCGGTAATAGCGGCAGA 3' |
| BGIBMGA005673 | 5' TGCTATGGGTGTGGGTGAAATC 3' | 5' GGAAGGCGTCAAAACGAATG 3' |
| BGIBMGA000680 | 5' CCATACTACTGCGGTGTCGGTG 3' | 5' CATTCCAATCTTGAACGGGCTTA 3' |
| BGIBMGA010023 | 5' TGTTTCTCTGGAGCCTTCTACCG 3' | 5' GAGTGTTTCCCCAACCGATGA 3' |
| BGIBMGA000583 | 5' GAGCAGGGTGATTAGAGCGTTGT 3' | 5' CCCACTCGTGAGGAGCGGTA 3' |
| BGIBMGA010811 | 5' CAACCCAACAGTTATCGCCG 3' | 5' GCTCTCGCATCATCTCCACAT 3' |
| BGIBMGA007377 | 5' GAGTCACAACCAGAACCATTGCTAT 3' | 5' TACCGACGAAGGAGAGGAACG 3' |
| BGIBMGA001320 | 5' GACCCTGAAAACCATCACCCA 3' | 5' CGGAGTCGCCGAAGCAAGT 3' |
| BGIBMGA004002 | 5' CACTGAGCCAATCGTGCCCT 3' | 5' GACTTCATCGGACTCGTCAACAA 3' |
| BGIBMGA004121 | 5' CCATCAATAGTCCCAGCACCG 3' | 5' CGCTCACAGCACCACCGTCT 3' |
| BGIBMGA008867 | 5' AATGGATTCAGGTTTGGACGC 3' | 5' CCGACGCTTCTCTTCTTGTTCT 3' |
| BGIBMGA014369 | 5' CGGCTCCCTATGGCTTTGG 3' | 5' CGGTCAGGACAGTCATCTTCGTG 3' |
| BGIBMGA004869 | 5' GTATTGTTGTTTGTTGTGGCAGC 3' | 5' CGTGGACTTCGGGATTCTCA 3' |
| BGIBMGA006775 | 5' GTGCCAGAGGTTCATCCAGC 3' | 5' TGATACAGCCATAGCGGTTCC 3' |
| BGIBMGA010062 | 5' GACGGCAACCTCCACAAGC 3' | 5' CAGGGGCACCCAAGTCAGTA 3' |
| BGIBMGA006518 | 5' CCACGAAGCCAGAAGGATTGT 3' | 5' AAGACGGAGGTAGCGAAGGAG 3' |
| BGIBMGA009012 | 5' TACAACGATGTGCCCAGTGC 3' | 5' CCTTCTTGAGTCCAGCAAATACC 3' |
| BGIBMGA009319 ( | 5' CGATTCAACATTCCAGAGCA 3' | 5' GAACACCATAGCAAGCACGAC 3' |
The LC50 value of B. mori larvae infected with BmNPV.
| Strains | LC50 | 95% fiducial limits | |
|---|---|---|---|
| (OB/mL) | Lower | Upper | |
| 2.27×106 | 4.58×105 | 1.74×107 | |
| 5.90×107 | 2.14×107 | 3.22×108 | |
| 1.03×105 | 3.96×104 | 2.24×105 | |
Summary statistics for silkworm genes based on the RNA-seq data.
| P50- | P50+ | BC9- | BC9+ | |
|---|---|---|---|---|
| Total Reads | 34,202,992 | 39,598,483 | 33,696,273 | 36,941,634 |
| GC Content (%) | 48 | 49 | 48 | 48 |
| % ≥ Q30 (%) | 91.42 | 90.74 | 90.07 | 90.28 |
| Mapped Reads | 27,261,542 | 31,333,514 | 26,640,096 | 29,131,867 |
| Mapped Ratio (%) | 79.72 | 79.08 | 79.06 | 78.89 |
| Unique Mapped Reads | 23,563,245 | 26,329,862 | 23,325,074 | 25,650,914 |
| Unique Mapped Ratio (%) | 68.90 | 66.51 | 69.21 | 69.47 |
Fig 1Length distribution of unigenes in the assembled transcriptomes.
The x axis represents different groups and treatments and the y axis shows the number of unigenes.
Fig 2Correlation between gene expression ratios obtained from transcriptome data and RT-qPCR.
(A) Expression ratios (FPKM fold change) obtained from transcriptome data (red) and RT-qPCR (blue). (B) Lineage analysis between the transcriptome and RT-qPCR. The ratios obtained by RT-qPCR (x-axis) were plotted against the ratios obtained by RNA-Seq (y-axis).
Fig 3Venn diagram showing the DEGs related to BmNPV infection in different resistant strains.
The number of up-regulated, down-regulated and unique DEGs of the pairwise comparisons of the experimental groups.
Shared numbers of DEGs are also shown in Fig 3.
| Groups | Total | Up-regulated genes | Down-regulated genes | Unique genes |
|---|---|---|---|---|
| 285 | 122 (43%) | 163 (57%) | 197 | |
| 193 | 56 (29%) | 137 (71%) | 119 | |
| 154 | 78 (51%) | 76 (49%) | 82 |
Fig 4Gene ontology (GO) analysis of DEGs in different comparable groups.
These genes were divided into groups based on cellular component, molecular function, and biological process. The percent of DEGs that could be assigned to the different categories are indicated.
DEGs involved in protein metabolism, cytoskeleton, and apoptosis after BmNPV infection in different resistant strains.
| Name | Gene ID | P50- FRKM | P50+ FPKM | BC9- FPKM | BC9+ FPKM | P50+ vs. P50- ratio | BC9+ vs. BC9- ratio |
|---|---|---|---|---|---|---|---|
| Hypothetical protein KGM_08787 | BGIBMGA003894 | 6.479 | 7.031 | 6.991 | 4.125 | 1.085 | 0.590 |
| B(0,+)-type amino acid transporter 1 | BGIBMGA007713 | 34.455 | 33.024 | 25.861 | 18.795 | 0.958 | 0.727 |
| L-asparaginase | BGIBMGA012995 | 21.645 | 24.361 | 21.849 | 16.429 | 1.125 | 0.752 |
| NEDD8-conjugating enzyme UBE2F | BGIBMGA013486 | 8.256 | 7.871 | 7.639 | 10.033 | 0.953 | 1.313 |
| 4-aminobutyrate aminotransferase | BGIBMGA006823 | 106.219 | 101.463 | 117.167 | 155.906 | 0.955 | 1.331 |
| Uncharacterized protein LOC101742492 | BGIBMGA006234 | 21.208 | 16.606 | 15.485 | 14.839 | 0.783 | 0.958 |
| Proton-coupled amino acid transporter 4 | BGIBMGA001151 | 1.715 | 3.412 | 2.198 | 1.239 | 1.990 | 0.564 |
| Y+L amino acid transporter 2 | BGIBMGA010801 | 1.541 | 2.816 | 2.030 | 1.249 | 1.827 | 0.615 |
| Solute carrier family 12 member 6 | BGIBMGA003629 | 1.068 | 1.736 | 0.867 | 0.564 | 1.625 | 0.651 |
| Cystathionine gamma-lyase | BGIBMGA003656 | 219.509 | 270.108 | 184.300 | 138.484 | 1.231 | 0.751 |
| Actin | BGIBMGA013945 | 945.736 | 1115.438 | 637.646 | 1057.763 | 1.179 | 1.659 |
| Muscle LIM protein isoform 1 | BGIBMGA001202 | 124.039 | 124.062 | 89.846 | 127.161 | 1.000 | 1.415 |
| Apolipophorins isoform X2 | BGIBMGA013341 | 2.345 | 3.642 | 2.198 | 2.856 | 1.553 | 1.300 |
| Putative villin | BGIBMGA003119 | 6.824 | 6.585 | 7.700 | 9.502 | 0.965 | 1.234 |
| Zinc finger protein Gfi-1b | BGIBMGA006132 | 12.448 | 18.952 | 12.387 | 9.220 | 1.522 | 0.744 |
| Actin cytoskeleton-regulatory complex protein PAN1 | BGIBMGA004121 | 83.016 | 99.504 | 54.242 | 28.428 | 1.199 | 0.524 |
| Actin cytoskeleton-regulatory complex protein PAN1 | BGIBMGA004002 | 4834.384 | 6342.360 | 4000.747 | 1781.384 | 1.312 | 0.445 |
| Actin cytoskeleton-regulatory complex protein PAN1 | BGIBMGA010768 | 7.855 | 45.723 | 7.668 | 0.250 | 5.821 | 0.033 |
| Proteasomal ATPase-associated factor 1 | BGIBMGA003545 | 4.920 | 8.102 | 6.756 | 7.861 | 1.647 | 1.164 |
| Actin-binding protein | BGIBMGA013080 | 2.026 | 3.810 | 2.813 | 3.095 | 1.880 | 1.100 |
| ATPase family AAA domain-containing protein 3 | BGIBMGA000542 | 23.055 | 17.196 | 20.730 | 21.882 | 0.746 | 1.056 |
| Conventional protein kinase C | BGIBMGA014132 | 0.352 | 0.305 | 0.384 | 0.250 | 0.866 | 0.652 |
| Pyruvate dehydrogenase kinase | BGIBMGA003258 | 6.211 | 5.928 | 4.519 | 3.213 | 0.955 | 0.711 |
| P53 | BGIBMGA013185 | 0.714 | 0.687 | 0.675 | 0.552 | 0.963 | 0.818 |
| Creb | BGIBMGA006865 | 21.657 | 21.099 | 23.179 | 18.966 | 0.974 | 0.818 |
| Cytochrome c | BGIBMGA009012 | 1149.891 | 1072.848 | 1153.371 | 1464.034 | 0.933 | 1.269 |
| Cell death activator CIDE-B | BGIBMGA011008 | 4.881 | 4.655 | 4.116 | 6.451 | 0.954 | 1.567 |
| Caspase Nc | BGIBMGA002841 | 5.533 | 6.677 | 6.469 | 6.021 | 1.207 | 0.931 |
| cAMP-dependent protein kinase C1 | BGIBMGA011429 | 17.894 | 23.160 | 20.027 | 21.581 | 1.294 | 1.078 |
| Tak1 | BGIBMGA010752 | 6.565 | 8.039 | 6.933 | 7.573 | 1.224 | 1.092 |
| Apoptosis-inducing factor | BGIBMGA014381 | 0.836 | 1.080 | 0.633 | 0.725 | 1.291 | 1.145 |
| Protein kinase ASK1 | BGIBMGA010545 | 1.928 | 2.558 | 2.321 | 2.588 | 1.327 | 1.115 |
| Ribosomal protein S6 kinase, 90 kda | BGIBMGA011088 | 14.457 | 19.178 | 17.556 | 20.070 | 1.327 | 1.143 |
| Daxx | BGIBMGA007470 | 7.205 | 9.653 | 9.246 | 9.842 | 1.340 | 1.065 |
| TRAF6 | BGIBMGA001290 | 1.493 | 2.077 | 1.604 | 1.906 | 1.392 | 1.188 |
| TNFSF5 | BGIBMGA003585 | 0.257 | 0.206 | 0.376 | 0.577 | 0.799 | 1.535 |
| Survivin 2 | BGIBMGA003946 | 0.521 | 0.387 | 0.585 | 1.015 | 0.743 | 1.737 |
| App | BGIBMGA008317 | 0.075 | 0.032 | 0.045 | 0.093 | 0.433 | 2.059 |
| Buffy | BGIBMGA001845 | 0.261 | 0.047 | 0.000 | 0.000 | 0.181 | NA |
The ratio represents the fold change of FPKM values after infection with BmNPV: a ratio ≥ 1.2 indicates genes that were up-regulated, a ratio ≤ 0.83 indicates genes that were down-regulated. Abbreviation: na, not applicable.
Relative FPKMs of innate immune-related genes in silkworm after BmNPV infection in different resistant strains.
| Description | Gene ID | P50- FRKM | P50+ FPKM | BC9- FPKM | BC9+ FPKM | P50+ vs. P50- ratio | BC9+ vs. BC9- ratio |
|---|---|---|---|---|---|---|---|
| Protein toll-like | BGIBMGA011084 | 0.016 | 0.035 | 0.008 | 0.074 | 2.142 | 9.010 |
| 18 wheeler | BGIBMGA011037 | 0.048 | 0.111 | 0.089 | 0.124 | 2.314 | 1.396 |
| Protein toll-like | BGIBMGA011034 | 1.936 | 2.607 | 1.903 | 1.829 | 1.347 | 0.962 |
| Slit homolog 2 protein | BGIBMGA011085 | 0.049 | 0.000 | 0.040 | 0.008 | 0.000 | 0.212 |
| Hypothetical protein KGM_16873 | BGIBMGA011216 | 30.386 | 28.239 | 23.694 | 25.300 | 0.929 | 1.068 |
| Toll-like receptor 13 | BGIBMGA008840 | 0.572 | 0.842 | 0.645 | 0.307 | 1.472 | 0.475 |
| Slit homolog 2 protein | BGIBMGA011025 | 0.112 | 0.128 | 0.061 | 0.070 | 1.144 | 1.157 |
| Slit homolog 3 protein | BGIBMGA011082 | 1.351 | 1.454 | 1.333 | 1.952 | 1.076 | 1.464 |
| Protein toll-like | BGIBMGA006244 | 0.182 | 0.207 | 0.226 | 0.093 | 1.139 | 0.412 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | BGIBMGA008389 | 2.825 | 3.434 | 3.333 | 3.683 | 1.216 | 1.105 |
| Nuclear factor NF-kappa-B p110 subunit isoform 1 | BGIBMGA002465 | 19.945 | 17.731 | 23.296 | 17.230 | 0.889 | 0.740 |
| Nuclear factor NF-kappa-B p110 subunit isoform 1 | BGIBMGA002464 | 41.624 | 37.288 | 44.316 | 36.213 | 0.896 | 0.817 |
| Serine protease inhibitor dipetalogastin | BGIBMGA009047 | 54.598 | 68.729 | 50.136 | 52.770 | 1.259 | 1.053 |
| Serine protease inhibitor 6 | BGIBMGA007729 | 0.372 | 0.858 | 0.549 | 0.350 | 2.308 | 0.638 |
| C-type lectin 10 | BGIBMGA006768 | 1.300 | 3.213 | 1.591 | 1.503 | 2.472 | 0.945 |
| Macrophage mannose receptor 1 | BGIBMGA002288 | 0.133 | 0.392 | 0.000 | 0.066 | 2.940 | na |
| Beta-1,3-glucan recognition protein 2 | BGIBMGA011609 | 12.509 | 7.548 | 33.869 | 7.289 | 0.603 | 0.215 |
| Peptidoglycan-recognition protein SC2 | BGIBMGA000584 | 3.019 | 4.118 | 3.421 | 3.479 | 1.364 | 1.017 |
| Peptidoglycan recognition protein S6 | BGIBMGA012866 | 0.722 | 0.253 | 0.734 | 0.081 | 0.351 | 0.110 |
| Attacin | BGIBMGA002739 | 0.193 | 0.000 | 0.098 | 0.048 | 0.000 | 0.495 |
| Attacin precursor | BGIBMGA002747 | 1.055 | 0.974 | 0.820 | 0.145 | 0.923 | 0.177 |
| Cecropin-A precursor | BGIBMGA006280 | 0.481 | 0.000 | 0.328 | 0.325 | 0.000 | 0.989 |
| Defense protein precursor | BGIBMGA014360 | 0.162 | 8.504 | 4.234 | 0.200 | 52.588 | 0.047 |
| Gloverin 1 precursor | BGIBMGA013863 | 1.805 | 1.326 | 6.944 | 0.684 | 0.735 | 0.098 |
| Gloverin 2 precursor | BGIBMGA005658 | 17.719 | 9.138 | 14.492 | 3.872 | 0.516 | 0.267 |
| Gloverin 3 precursor | BGIBMGA013803 | 3.068 | 2.236 | 1.915 | 1.245 | 0.729 | 0.650 |
| Hemolin | BGIBMGA008736 | 0.000 | 0.022 | 52.634 | 0.136 | na | 0.003 |
| Lebocin-3precursor | BGIBMGA006775 | 4.279 | 2.530 | 26.723 | 0.912 | 0.591 | 0.034 |
| Lysozyme | BGIBMGA007458 | 1.936 | 4.622 | 0.876 | 2.108 | 2.387 | 2.407 |
| Moricin 1 | BGIBMGA011495 | 0.000 | 0.000 | 0.379 | 0.192 | na | 0.507 |
The ratio represents the fold change in the FPKM value after infection with BmNPV; a ratio ≥ 1.2 indicates genes that were up-regulated, a ratio ≤ 0.83 indicates genes that were down-regulated. Abbreviation: na, not applicable.
Relative FPKMs of 22 DEGs of interest in BC9 following BmNPV infection.
| Name | Gene ID | P50- FPKM | P50+ FPKM | BC9- FPKM | BC9+ FPKM | BC9- vs. P50- FPKM | BC9+_vs._BC9- FPKM |
|---|---|---|---|---|---|---|---|
| Peptidoglycan-recognition protein 2 | BGIBMGA000583 | 300.13 | 229.37 | 197.96 | 121.57 | 0.66 | 0.61 |
| Adenylate cyclase type 5 | BGIBMGA002064 | 3.52 | 2.39 | 3.48 | 1.14 | 0.99 | 0.33 |
| Pyruvate dehydrogenase kinase | BGIBMGA003258 | 6.21 | 5.93 | 4.52 | 3.21 | 0.73 | 0.71 |
| MFS-type transporter | BGIBMGA003409 | 50.65 | 47.67 | 15.50 | 6.82 | 0.31 | 0.44 |
| Actin cytoskeleton-regulatory complex protein PAN1 | BGIBMGA004121 | 83.02 | 99.50 | 54.24 | 28.43 | 0.65 | 0.52 |
| B(0,+)-type amino acid transporter 1 | BGIBMGA007713 | 34.46 | 33.02 | 25.86 | 18.79 | 0.75 | 0.73 |
| EF-hand domain-containing protein CG10641 | BGIBMGA008867 | 36.74 | 28.33 | 25.33 | 18.58 | 0.69 | 0.73 |
| Lactase-phlorizin hydrolase | BGIBMGA010811 | 1751.88 | 1141.90 | 913.76 | 411.25 | 0.52 | 0.45 |
| EN protein binding/engrailed nuclear homeoprotein-regulated protein | BGIBMGA011701 | 49.08 | 54.49 | 37.03 | 27.34 | 0.75 | 0.74 |
| Antimicrobial protein 6Tox | BGIBMGA000861 | 0.59 | 0.37 | 3.91 | 0.26 | 6.57 | 0.07 |
| Facilitated trehalose transporter Tret1 | BGIBMGA004426 | 3.90 | 6.88 | 9.06 | 3.19 | 2.32 | 0.35 |
| Protease inhibitor 6 | BGIBMGA004869 | 7.51 | 6.49 | 51.58 | 4.39 | 6.86 | 0.09 |
| Lebocin-3 | BGIBMGA006775 | 4.28 | 2.53 | 26.72 | 0.91 | 6.25 | 0.03 |
| 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha | BGIBMGA007880 | 7.70 | 2.58 | 17.19 | 8.46 | 2.23 | 0.49 |
| Hemolin | BGIBMGA008736 | 0.00 | 0.02 | 52.63 | 0.14 | NA | 0.00 |
| Integument esterase 2 | BGIBMGA009544 | 2.39 | 2.49 | 8.48 | 1.12 | 3.55 | 0.13 |
| Alanine aminotransferase 2 | BGIBMGA011984 | 0.34 | 0.13 | 9.50 | 0.13 | 27.59 | 0.01 |
| Otoferlin | BGIBMGA012258 | 0.02 | 0.04 | 2.23 | 0.05 | 96.93 | 0.02 |
| U2AF function domain protein | BGIBMGA013991 | 0.00 | 0.07 | 2.95 | 0.15 | NA | 0.05 |
| Defense protein precursor | BGIBMGA014360 | 0.16 | 8.50 | 4.23 | 0.20 | 26.18 | 0.05 |
| Prostatic acid phosphatase | BGIBMGA014369 | 71.98 | 60.03 | 111.41 | 54.97 | 1.55 | 0.49 |
| Zinc Ribbon domain protein | NewGene_1603 | 0.00 | 0.00 | 2.17 | 0.00 | NA | 0.00 |
The ratio represents the fold change in the FPKM value after infection with BmNPV; a ratio ≥ 1.2 indicates genes that were up-regulated, a ratio ≤ 0.83 indicates genes that were down-regulated. Abbreviation: na, not applicable.
Fig 5Expression patterns of selected genes related to BmNPV resistance in different resistant strains.
Each row represents a different gene, with blue, yellow and red indicating low, medium and high levels of gene expression, respectively.
Fig 6Real-time PCR analysis of expression profiles of several genes in B. mori midgut.
After removing genetic background and individual immune stress response genes, 22 differentially expressed genes of interest potentially involved in resistance to NPV infection were obtained. Additionally, 119 genes unique differentially expressed in the isogenic-line BC9 (resistant strain) following BmNPV infection were observed. In order to further conformed the function of these genes, 4 genes from 22 DEGs and 5 genes from 119 DEGs with well reported previously were selected to conduct RT-qPCR.
Fig 7Hypothesized modal analysis of the roles of the screened DEGs in BmNPV infection pathway.
V-ATPase is activated by LPH to promote viral entry into the cytoplasm, a process which was also effected by PAN1 and otoferlin. BAT1 related channel could serve as an alternative pathway for virus transmembrane transport. The released nucleocapsid is transported into the nucleus with the help of EFP. During replication, EFHP, ASGPA, ALT2, U2AF, ACT5 and ZRDP play an important role in facilitating virus replication. MFS is induced by the virus to increase cell volume leading to cell death. At the same time, the apoptosis process could be triggered by PDK to inhibit BmNPV infection.